Table 2

Error component logit

		Estimate	P value	95% CI lower bound	95% CI upper bound	Relative attribute importance	Minimum acceptable survival
Alternative specific constant	Treatment	5.1339	0.0002	2.4566	7.8112	–	–
Alternative specific constant	SD of treatment	4.0982	0.0001	2.0411	6.1553	–	–
Fatigue	Grade 2 fatigue	−0.2948	0.0101	−0.5194	−0.0702	0.0590	2.5419
Nausea	Grade 1 nausea	−0.4196	0.0519	−0.8426	0.0034	0.1091	3.6178
Nausea	Grade 2 nausea	−0.5446	0.0093	−0.9550	−0.1342	0.1091	4.6960
Diarrhoea	Grade 1 diarrhoea	0.0241	0.8806	−0.2898	0.3379	0.1519	−0.2074 N.S.
Diarrhoea	Grade 2 diarrhoea	−0.7343	0.0004	−1.1384	−0.3302	0.1519	6.3314
Additional side effects	Grade 2 peripheral neuropathy	−1.2087	0.0000	−1.6458	−0.7715	0.2793	10.4211
	Grade 2 hand–foot syndrome	−1.3946	0.0000	−1.8404	−0.9489		12.0247
	Grade 2 mucositis	−1.2764	0.0000	−1.6668	−0.8861		11.0055
Overall survival	Annual probability of survival	0.1160	0.0000	0.0847	0.1473	0.3485	–
Urgent hospital admission	Probability of urgent hospital admission in the first year of treatment	0.0090	0.1068	−0.0019	0.0199	0.0522 N.S.	−2.3236 N.S. (for 30% level)
Model statistics
Number of individuals	105
Observations	601
Log likelihood	−379.9434
Bayesian info criterion	836.6699

N.S, not significant.